Levrx and Waltz Health Unite to Combat Opaque U.S. Drug Pricing

TROY, N.Y. – April 01, 2026 – In a move aimed at simplifying the notoriously complex world of prescription drug pricing, Levrx and Waltz Health announced a partnership today that integrates a transparent pharmacy marketplace directly into a member’s benefit navigation platform. The collaboration promises to give consumers and their health plan sponsors a clearer, more direct path to lower medication costs.

The partnership brings Waltz Health's AI-driven marketplace into the Levrx pharmacy navigation hub. This creates a single digital experience where patients can see and compare medication prices, including insurance co-pays and cash-pay discount options, side-by-side.

A Crisis of Cost and Complexity

The announcement comes at a time of intense pressure on the U.S. healthcare system, where soaring prescription drug costs have become a critical issue for households and employers alike. Recent studies paint a stark picture: a 2026 poll from the Kaiser Family Foundation found that about four in ten adults have not taken their medication as prescribed in the past year due to cost. For employers and other plan sponsors, the challenge is equally daunting, with specialty medications—which represent less than 5% of prescriptions—now accounting for more than half of all drug spending.

Historically, navigating this landscape has been a frustrating exercise for patients. Plan sponsors often implement various cost-saving programs, but these solutions frequently exist as separate, disconnected services. This fragmentation forces members to juggle multiple vendors and websites without clear guidance, often leading to missed opportunities for savings. Levrx addresses this by consolidating a plan sponsor's entire pharmacy benefit strategy, including vendor programs and fulfillment options, into one unified hub.

"Pharmacy savings programs only work when members can actually see and use them," said Vikash Agrawal, Executive Chairman of Levrx, in the announcement. "Our platform brings pharmacy benefits, programs, and pricing options into one experience where members can understand their choices and take action."

A Unified Front Through Technology

The new integration aims to cut through the confusion by embedding Waltz Health's cost-containment tools directly within the Levrx user experience. Waltz Health utilizes artificial intelligence to create what it calls a "high-speed smart lane" within the traditional Pharmacy Benefit Manager (PBM) process. This technology scours a curated marketplace of data sources to find and route prescriptions to the most cost-effective options.

Through the partnership, these transparent prices and alternative fulfillment pathways will now appear seamlessly within the Levrx platform. Members will not only see the prices but also receive guidance on when a discount card or other program might offer a better deal than their standard insurance benefit.

"Employers and health plans want access to lower drug prices, but they also need those options to work seamlessly inside the existing pharmacy benefit," stated Jeff Park, President of Waltz Health. "Through our integration with Levrx, those choices surface directly in the member experience where they can influence medication decisions."

The collaboration specifically targets high-cost areas like specialty medication management. Waltz Health's "Waltz Connect" platform, which focuses on these expensive drugs, has demonstrated significant results. In a recent partnership with Serve You Rx, the platform delivered an average savings of $917 per specialty prescription, cutting costs by 14% and driving a 90% conversion rate to more affordable biosimilar alternatives. By integrating such powerful tools, the partnership seeks to deliver tangible savings for both members and the employers who sponsor their health plans.

Vikram Agrawal, President and CEO of Levrx, added, "By integrating Waltz Health into the Levrx experience, we are expanding transparent pricing pathways and giving members visibility and education around the solutions their plan sponsor has implemented to help them save."

Challenging the Pharmacy Benefit Status Quo

This partnership enters a market dominated by three large, vertically integrated PBMs—CVS Caremark, Express Scripts, and Optum Rx—which together control roughly 80% of all prescription claims. These incumbents have faced growing scrutiny from lawmakers and employers over opaque business practices, such as spread pricing and a complex system of rebates that can obscure the true cost of drugs.

The Levrx-Waltz model represents a significant step in the growing "unbundling" trend, where employers are moving away from single, all-in-one PBM contracts. Instead, they are opting to build "virtual PBMs" by contracting with best-in-class vendors for specific functions like claims processing, specialty drug management, and member engagement. This approach offers greater flexibility, data transparency, and, crucially, cost control.

By combining a top-tier member engagement platform with a proven transparent pricing engine, the two companies are offering a solution that directly addresses the core criticisms leveled against the traditional PBM model. It provides plan sponsors with a powerful tool to carve out their pharmacy benefits and regain control over a significant portion of their healthcare spend. The emphasis on member engagement is critical, as a high Net Promoter Score of 87 for Waltz Health’s tools suggests that when users are given clear, actionable information, they are highly satisfied and more likely to adopt cost-saving behaviors.

As the demand for accountability and transparency in healthcare continues to mount, such integrated, technology-driven solutions are poised to play an increasingly important role. The partnership signals a clear move toward empowering consumers and plan sponsors with the data they need to make financially sound decisions in a market that has long been defined by its opacity.